Diabetic nephropathy

References

• Bakris GL. The effects of calcium antagonists on renal hemodynamics, urinary protein excretion, and glomerular morphology in diabetic states. J Am Soc Nephrol 1991: 2(2 Suppl 1): S21–9
   PubMed Web of Science ®Google Scholar
• Bakris GL. Calcium abnormalities and the diabetic, hypertensive patient: implications for renal preservation. In: Epstein M, ed. Calcium antagonists in clinical medicine. Philadelphia: Hanley & Belfus, 1992: 367–89
   Google Scholar
• Earle K, Walker J, Hill C, et al. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992: 326(10): 673–7
   PubMed Web of Science ®Google Scholar
• Krolewski AS, Canessa M, Warram JH, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988: 318(3): 140–5
   PubMed Web of Science ®Google Scholar
• Mogensen CE. Prevention and treatment of renal disease in insulin-dependent diabetes mellitus. Semin Nephrol 1990: 10(3): 260–73
   PubMed Web of Science ®Google Scholar
• Parving HH. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991: 14(3): 260–9
   PubMed Web of Science ®Google Scholar
• Parving HH, Smith UN, Amities ER, et al. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. (Abstr) J Am Soc Nephrol 1990: 1(3): 254
   Google Scholar
• Anderson S, Rennke HG, Garcia DL, et al. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989: 36(4): 526–36
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Shiraga H, Yoshida Y, et al. “Intact nephrons” as the primary origin of proteinuria in chronic renal disease: study in the rat model of subtotal nephrectomy. J Clin Invest 1988,82(5): 1614–23
   PubMed Web of Science ®Google Scholar
• Brown S, Walton C, Crawford P, et al. Renal response to angiotensin converting enzyme inhibition or calcium channel blockade in diabetic beagles. J Am Soc Nephrol (Abstr) 1991: 2(3): 286
   Google Scholar
• Zatz R, Dunn BR, Meyer TW et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986: 77(6): 1925–30
   PubMed Web of Science ®Google Scholar
• Sandeman DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 1992: 327(11): 760–4
   PubMed Web of Science ®Google Scholar
• Myers BD. Pathophysiology of proteinuria in diabetic glomerular disease. J Hypertens Suppl 1990: 8(1): S41–6
   PubMedGoogle Scholar
• Ghiggeri GM, Candiano G, Ginevri F, et al. Hypertension and renal selectivity properties in diabetic microalbuminuria. Nephrol Dial Transplant 1990: 5(Suppl 1): 66–8
   PubMedGoogle Scholar
• Kaysen GA, Myers BD, Couser WG, et al. Mechanisms and consequences of proteinuria. Lab Invest 1986: 54(5): 479–98
   PubMed Web of Science ®Google Scholar
• Mogensen CE, Pedersen M, Christiansen JS, et al. Potential renal protective effect of ACE inhibitors in early and overt diabetic nephropathy as compared with other antihypertensive agents. In: Dollery CT, Sherwood LM, eds. Cardiac and renal failure: an expanding role for ACE inhibitors. Philadelphia: Hanley & Belfus, 1989: 287–328
   Google Scholar
• Myers BD, Meyer TW. Angiotensin-converting enzyme inhibitors in the prevention of experimental diabetic glomerulopathy. Am J Kidney Dis 1989: 13(1): 20–4
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Puntorieri S, Battaglia C, et al. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macro-molecules and water and lessens glomerular injury in the rat. J Clin Invest 1990: 85(2): 541–9
   PubMed Web of Science ®Google Scholar
• Hostetter TH, Rosenberg ME. Hemodynamic effects of glomerular permselectivity. Am J Nephrol 1990: 10(Suppl 1): 24–7
   PubMedGoogle Scholar
• Mauer SM, Steffes MW, Ellis EN, et al. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984: 74(4): 1143–55
   PubMed Web of Science ®Google Scholar
• Steffes MW, Osterby R, Chavers B, et al. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989: 38(9): 1077–81
   PubMed Web of Science ®Google Scholar
• Chavers BM, Bilous KW, Ellis EN, et al. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 1989: 320(15): 966–70
   PubMed Web of Science ®Google Scholar
• Ayo SH, Radnik RA, Glass WF 2d, et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 1991;260(2 Pt 2): F185–91
   PubMed Web of Science ®Google Scholar
• Bhandaru S, Bakris GL. Insulin potentiates the attenuating effects of high glucose medium on mesangial mitogenesis. (Abstr) J Am Soc Nephrol 1991: 2(3): 285
   Google Scholar
• Ayo SH, Radnik RA, Garoni JA, et al. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990;136(6): 1339–48 [erratum, Am J Pathol 1990: 137(2): preceding 225]
   PubMed Web of Science ®Google Scholar
• Bakris GL, Akerstrom V, Re R. Insulin, angiotensin II antagonism and converting enzyme inhibition: effects on human mesangial cell mitogengenicity and endothelin. (Abstr) Hypertension 1990: 16(3): 326
   Web of Science ®Google Scholar
• Nahman NS, Leonhart K, Csio FG. Effect of Captopril in fibronectin production by human mesangial cells cultured in high glucose. (Abstr) Clin Res 1990: 38(4): 849
   Google Scholar
• Gaber L, Walton C, Crawford P, et al. Converting enzyme inhibition or calcium antagonism alone or combined on histologic progression of diabetic nephropathy. (Abstr) J Am Soc Nephrol 1992: 3(3): 332
   Google Scholar
• Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int 1992: 41(4): 891–7
   PubMed Web of Science ®Google Scholar
• Holdaas H, Hartmann A, Lien MG, et al. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Intern Med 1991: 229(2): 163–70
   PubMed Web of Science ®Google Scholar
• Ferder L, Daccoidi H, Martello M, et al. Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients. Hypertension 1992: 19(2 Suppl): II237–42
   PubMedGoogle Scholar
• Demarie BK, Bakris GL. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990: 113(12): 987–8
   PubMed Web of Science ®Google Scholar
• Mickisch O, Schmid M, Mann JF, et al. [Calcium antagonists in chronic renal failure: undesirable effects on glomerular hemodynamics?] Dtsch Med Wochenschr 1988: 113(40): 1546–8(Ger)
   PubMed Web of Science ®Google Scholar
• Zucchelli P, Zuccala A, Borghi M, et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992: 42(2): 452–8
   PubMed Web of Science ®Google Scholar
• Bohler J, Woitas R, Keller E, et al. Effect of nifedipine and Captopril on glomerular hyperfiltration in normotensive man. Am J Kidney Dis 1992: 20(2): 132–9
   PubMed Web of Science ®Google Scholar
• Viberti GC, Hill RD, Jarrett RJ, et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982: 1(8287): 1430–2
   PubMed Web of Science ®Google Scholar
• Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984: 310(6): 356–60
   PubMed Web of Science ®Google Scholar
• Weir M, Bakris GL. Albuminuria in hypertensive diabetics: is it an important variable in treatment? In: Therapeutic approaches to the diabetic hypertensive patient. Proceedings of a symposium. Minneapolis: McGraw-Hill Healthcare Publications, 1993: 23–30 (Postgraduate Medicine: A Special Report, January 1993)
   Google Scholar
• Rossing P, Hommel E, Smidt UM, et al. Reduction in albuminuria predicts a beneficial effect on progression in diabetic nephropathy during antihypertensive treatment. J Am Soc Nephrol (Abstr) 1992: 3(3): 338
   Google Scholar
• Daniels B, Hostetter T. Glycated albumin increases free radical production by mesangial cells. (Abstr) Clin Res 1992: 41(4): 724
   Google Scholar
• Ziyadeh FN, Cohen MP. Monoclonal antibody against glycated albumin blocks the suppressive effect of glycated plasma on mesangial cell proliferation. (Abstr) J Am Soc Nephrol 1992: 3(3): 770
   Google Scholar
• Mogensen CE. Captopril delays progression to overt renal disease in insulin dependent diabetes mellitus patients with microalbuminuria. (Abstr) J Am Soc Nephrol 1992: 3(3): 336
   Google Scholar
• Slataper R, Sadler R, Vicknair N, et al. Normalization of glomerular filtration rate in normotensive hyperfiltering, type I diabetic patients preserves renal function. (Abstr) Am J Hypertens 1992: 5(5): 72
   Google Scholar
• Mathiesen ER, Hommel E, Giese J, et al. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991: 303(6794): 81–7
   PubMed Web of Science ®Google Scholar
• Marre M, Chatellier G, Leblanc H, et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988: 297(6656): 1092–5
   PubMedGoogle Scholar
• Metcalf P, Baker J, Scott A, et al. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem 1992: 38(9): 1802–8
   PubMed Web of Science ®Google Scholar
• Weidmann P, Uehlinger DE, Gerber A. Antihypertensive treatment and serum lipoproteins. J Hypertens 1985: 3(4): 297–306
   PubMed Web of Science ®Google Scholar
• Pollare T, Lithell H, Morlin C, et al. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 1989: 7(7): 551–9
   PubMed Web of Science ®Google Scholar
• Skinner MH, Futterman A, Morrissette D, et al. Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann Intern Med 1992: 116(8): 615–23
   PubMed Web of Science ®Google Scholar
• Romero R, Salinas I, Lucas A, et al. Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients. Diabetes Res Clin Pract 1992: 17(3): 191–8
   PubMed Web of Science ®Google Scholar
• Weidmann P, Boehlen L, de Courteu M, et al. Human diabetic proteinuria is affected differently by ACE inhibitors, calcium antagonists or conventional therapy. J Am Soc Nephrol (Abstr) 1992: 3(3): 339
   Google Scholar